Search for: "Incyte Corporation"
Results 1 - 20
of 23
Sorted by Relevance
|
Sort by Date
5 May 2021, 6:32 am
On May 4, 2021, the Department of Justice announced that Incyte Corporation, a Delaware-based pharmaceutical company, agreed to pay $12.6 million to resolve allegations that it used a foundation, Chronic Disease Fund dba Good Days (“CDF”), to funnel kickbacks to Medicare patients taking its own drug. [read post]
7 May 2021, 12:09 pm
The Department of Justice announced this week that Incyte Corporation, a Delaware pharmaceutical company, has agreed to pay $12.6 million to resolve allegations that it violated the False Claims Act by paying kickbacks to a charitable foundation to increase prescriptions for the drug Jakafi, which is used to treat myelofibrosis, a form of leukemia that causes extensive scarring in bone marrow and leads to severe anemia and fatigue. [read post]
10 Apr 2024, 3:00 pm
Panuwat traded in the stock of Incyte Corporation based on highly confidential information. [read post]
5 May 2021, 1:36 pm
Department of Justice (DOJ) announced that pharmaceutical company Incyte Corporation has agreed to pay $12.6 million to resolve allegations that it violated the False Claims Act. [read post]
8 Jan 2018, 10:07 am
The Court of Justice of the European Union (“CJEU”), in its recent judgment of 20 December 2017 (Case C-492/16, Incyte Corporation vs. [read post]
14 Apr 2024, 4:46 pm
Rather than buying the securities of Medivation, however, Panuwat used his employer’s confidential information to acquire a large stake in call options of another comparable public company, Incyte Corporation, whose share price increased materially on the important news. [read post]
6 Dec 2023, 11:25 am
Rather, within minutes of hearing the news, Panuwat purchased out-of-the-money call options in Incyte Corporation, another oncology-focused biopharmaceutical company that he believed would increase in value when the Medivation acquisition was announced. [read post]
20 Aug 2021, 5:55 am
Rather, within minutes of hearing from the CEO, Panuwat purchased out-of-the-money call options in Incyte Corporation, another mid-cap oncology-focused biopharmaceutical company that he believed would increase in value when the Medivation acquisition was announced. [read post]
8 Sep 2021, 12:32 pm
., engaged in insider trading when he acquired securities of a rival company, Incyte Corporation. [read post]
9 Apr 2024, 3:12 am
Rather than buying the securities of Medivation, however, Panuwat used his employer’s confidential information to acquire a large stake in call options of another comparable public company, Incyte Corporation, whose share price increased materially on the important news. [read post]
28 Feb 2023, 9:05 pm
Instead, prior to the release of this price-sensitive information, the insider purchased short-term, out-of-the-money options in Incyte (INCY), a related mid-sized biopharmaceutical company. [read post]
17 Dec 2023, 6:30 am
Related research from the Program on Corporate Governance includes Insider Trading via the Corporation (discussed on the Forum here) by Jesse M. [read post]
17 Dec 2023, 6:30 am
Related research from the Program on Corporate Governance includes Insider Trading via the Corporation (discussed on the Forum here) by Jesse M. [read post]
14 Sep 2021, 1:54 pm
Rather, within minutes of hearing the news, Panuwat purchased out-of-the-money call options in Incyte Corporation, another oncology-focused biopharmaceutical company that he believed would increase in value when the Medivation acquisition was announced. [read post]
8 Nov 2021, 6:42 am
The twist was that he didn’t trade in Medivation or Pfizer stock, but rather Incyte Corporation, another mid-cap oncology-focused biopharmaceutical company. [read post]
18 Aug 2021, 3:30 am
Panuwat did not inform anyone at Medivation about his Incyte trades. [read post]
28 Nov 2023, 9:15 pm
Would the court have reached a different conclusion if analysts and insiders had not mentioned Incyte as a comparable company, or if Panuwat had not been aware of those references? [read post]
14 Apr 2024, 9:05 pm
Rather, he purchased shares in Incyte Corporation, which was a firm arguably occupying the same market space as Medivation. [read post]
7 May 2021, 1:36 pm
A former compliance executive was the whistleblower in an FCA case against pharmaceutical company Incyte Corporation, and a compliance professional was the whistleblower in an FCA case against Halifax Hospital. [read post]
27 Aug 2021, 3:15 am
This Wachtell Lipton memo expands on issues the case could turn on: Most corporate insider trading policies include a provision similar to Medivation’s prohibition of trades in the securities of other companies on the basis of the employer’s information. [read post]
